Dec 27, 2023
51:50
For every 50 shares held, investors received 51. The price per share adjusted from $344500.00 to $337745.10.
The split itself did not change the total investment value.
Hanmi Pharmaceutical Co., Ltd. (KRX:128940) operates in the Pharmaceuticals: major industry.
Hanmi Pharmaceutical Co., Ltd. company overviewHanmi Pharmaceutical Co., Ltd.'s most recent stock split was on December 27, 2023. It was a 51-for-50 forward split, so shareholders received 51 shares for every 50 they held.
Hanmi Pharmaceutical Co., Ltd. (KRX:128940) has split its stock 14 times: a 21-for-20 split on December 29, 2010, a 21-for-20 split on December 28, 2011, a 21-for-20 split on December 27, 2012, a 21-for-20 split on February 10, 2014, a 21-for-20 split on December 29, 2014, a 51-for-50 split on December 29, 2015, a 107-for-100 split on February 15, 2017, a 51-for-50 split on December 27, 2017, a 51-for-50 split on December 27, 2018, a 51-for-50 split on December 27, 2019, a 51-for-50 split on December 29, 2020, a 51-for-50 split on December 29, 2021, a 51-for-50 split on December 28, 2022, and a 51-for-50 split on December 27, 2023.
Hanmi Pharmaceutical Co., Ltd. has split its stock 14 times. This history records 14 forward splits between December 29, 2010 and December 27, 2023.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Hanmi Pharmaceutical Co., Ltd.'s 51-for-50 split on December 27, 2023, every 50 shares became 51 shares.
Hanmi Pharmaceutical Co., Ltd. has not announced a new split in our records. Its most recent split was on December 27, 2023, 2 years ago. Companies announce splits in advance, and any new KRX:128940 split will appear on this page.
Already premium?